Hepatorenal syndrome primary prevention

Hepatorenal syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hepatorenal syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hepatorenal syndrome primary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hepatorenal syndrome primary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hepatorenal syndrome primary prevention
CDC on Hepatorenal syndrome primary prevention
Hepatorenal syndrome primary prevention in the news
Blogs on Hepatorenal syndrome primary prevention
Directions to Hospitals Treating Hepatorenal syndrome
Risk calculators and risk factors for Hepatorenal syndrome primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sunny Kumar MD [2]

Overview

There is no primary prevention of hepatorenal syndrome.

Primary Prevention

There is no primary prevention of hepatorenal syndrome. Albumin reduces development of renal failure in patients having liver disease.